196 related articles for article (PubMed ID: 7506408)
1. Expanding multiple marker screening for Down's syndrome to include Edward's syndrome.
Barkai G; Goldman B; Ries L; Chaki R; Zer T; Cuckle H
Prenat Diagn; 1993 Sep; 13(9):843-50. PubMed ID: 7506408
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
3. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
5. Second-trimester maternal serum screening using alpha-fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: experience of a regional programme.
Goodburn SF; Yates JR; Raggatt PR; Carr C; Ferguson-Smith ME; Kershaw AJ; Milton PJ; Ferguson-Smith MA
Prenat Diagn; 1994 May; 14(5):391-402. PubMed ID: 7521964
[TBL] [Abstract][Full Text] [Related]
6. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.
Wald NJ; Cuckle HS; Densem JW; Kennard A; Smith D
Br J Obstet Gynaecol; 1992 Feb; 99(2):144-9. PubMed ID: 1372820
[TBL] [Abstract][Full Text] [Related]
8. Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.
Wald NJ; Kennard A; Densem JW; Cuckle HS; Chard T; Butler L
BMJ; 1992 Aug; 305(6850):391-4. PubMed ID: 1382768
[TBL] [Abstract][Full Text] [Related]
9. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening.
Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA
N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852
[TBL] [Abstract][Full Text] [Related]
10. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
11. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
Wald NJ; Watt HC; Hackshaw AK
N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum screening in Ontario using the triple marker test.
Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
[TBL] [Abstract][Full Text] [Related]
13. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
14. Four-marker serum screening for Down's syndrome.
Wald NJ; Densem JW; Smith D; Klee GG
Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
[TBL] [Abstract][Full Text] [Related]
15. The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18.
Leporrier N; Herrou M; Herlicoviez M; Leymarie P
Br J Obstet Gynaecol; 1996 Apr; 103(4):335-8. PubMed ID: 8605130
[TBL] [Abstract][Full Text] [Related]
16. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
17. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
[TBL] [Abstract][Full Text] [Related]
18. The triple-marker test in predicting fetal aneuploidy: a compromise between sensitivity and specificity.
Huderer-Duric K; Skrablin S; Kuvacic I; Sonicki Z; Rubala D; Suchanek E
Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):49-55. PubMed ID: 10659916
[TBL] [Abstract][Full Text] [Related]
19. Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Nanchahal K; Canick JA; Haddow JE; Knight GJ; Palomaki GE
Br J Obstet Gynaecol; 1988 Apr; 95(4):334-41. PubMed ID: 2454652
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum unconjugated oestriol and human chorionic gonadotrophin levels in pregnancies with insulin-dependent diabetes: implications for screening for Down's syndrome.
Wald NJ; Cuckle HS; Densem JW; Stone RB
Br J Obstet Gynaecol; 1992 Jan; 99(1):51-3. PubMed ID: 1372176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]